Gulbenkian Institute For Molecular Medicine
Clinical trials sponsored by Gulbenkian Institute For Molecular Medicine, explained in plain language.
-
Gut bacteria may hold key to early colorectal cancer detection
Diagnosis Recruiting nowThis study is looking for 400 adults in Portugal, aged 40 to 74, who have recently been diagnosed with colorectal cancer but haven't started treatment yet. Researchers want to see if analyzing the bacteria in a person's stool can help detect cancer earlier and predict outcomes. T…
Sponsor: Gulbenkian Institute for Molecular Medicine • Aim: Diagnosis
Last updated May 22, 2026 14:04 UTC
-
Gut microbiome study aims to revolutionize colorectal cancer detection
Knowledge-focused Recruiting nowThis study looks at bacteria in stool samples from 30,000 people aged 40-74 in Portugal to find new markers for early colorectal cancer detection. Researchers will compare gut microbiome patterns with standard screening tests and colonoscopy results. The goal is to develop a more…
Sponsor: Gulbenkian Institute for Molecular Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC